{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:59:19Z","timestamp":1788919159456,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T00:00:00Z","timestamp":1506729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T00:00:00Z","timestamp":1506729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Centre of Postgraduate Medical Education grant","award":["501-1-10-14-16"],"award-info":[{"award-number":["501-1-10-14-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40261-017-0577-1","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T10:08:45Z","timestamp":1506766125000},"page":"1175-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-4890","authenticated-orcid":false,"given":"Tomasz","family":"Imiela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Budaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,30]]},"reference":[{"issue":"9","key":"577_CR1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137\u201346.","journal-title":"Heart."},{"issue":"25","key":"577_CR2","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.111.019216","volume":"124","author":"JC Kelder","year":"2011","unstructured":"Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124(25):2865\u201373.","journal-title":"Circulation."},{"issue":"27","key":"577_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J."},{"issue":"6","key":"577_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","volume":"19","author":"R Kassamali","year":"2011","unstructured":"Kassamali R, Sica DA. Acetazolamide: a forgotten diuretic agent. Cardiol Rev. 2011;19(6):276\u20138.","journal-title":"Cardiol Rev."},{"issue":"6919","key":"577_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(56)90105-2","volume":"270","author":"T Hanley","year":"1956","unstructured":"Hanley T, Platts MM. Acetazolamide (diamox) in the treatment of congestive heart-failure. Lancet. 1956;270(6919):357\u20139.","journal-title":"Lancet."},{"issue":"1","key":"577_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1067\/mhj.2002.123144","volume":"144","author":"GW Neuberg","year":"2002","unstructured":"Neuberg GW, Miller AB, O\u2019Connor CM, Belkin RN, Carson PE, Cropp AB, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;144(1):31\u20138.","journal-title":"Am Heart J."},{"issue":"3","key":"577_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/AC.70.3.3080630","volume":"70","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB, Nijst P, Penders J, Dens J, et al. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol. 2015;70(3):265\u201373.","journal-title":"Acta Cardiol."},{"issue":"24","key":"577_CR8","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","volume":"59","author":"GM Felker","year":"2012","unstructured":"Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol. 2012;59(24):2145\u201353.","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"577_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","volume":"29","author":"H Knauf","year":"1997","unstructured":"Knauf H, Mutschler E. Sequential nephron blockade breaks resistance to diuretics in edematous states. J Cardiovasc Pharmacol. 1997;29(3):367\u201372.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"11","key":"577_CR10","doi-asserted-by":"publisher","first-page":"e79327","DOI":"10.1371\/journal.pone.0079327","volume":"8","author":"K Zahedi","year":"2013","unstructured":"Zahedi K, Barone S, Xu J, Soleimani M. Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications. PLoS One. 2013;8(11):e79327.","journal-title":"PLoS One."},{"issue":"14","key":"577_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847.","journal-title":"Eur Heart J."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-017-0577-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:44:13Z","timestamp":1650872653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-017-0577-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,30]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0577-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,30]]},"assertion":[{"value":"30 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was conducted thanks to a Centre of Postgraduate Medical Education Grant (Number 501-1-10-14-16). The study drug was provided free of charge by the Polish manufacturer (Polpharma).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Tomasz Imiela and Andrzej Budaj have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Postgraduate Medical School Ethics Committee (Approval No. 17\/PB\/2015) and all procedures in the study were in accordance with the 1964 Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}